Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease
Rafael A. García-Muñoz*, Joseph McConnell, Victoria Morales, Raul Sanz
Department of Chemical and Environmental Technology, Rey Juan Carlos University, Madrid, Spain (García-Muñoz RA, Morales V, Sanz R)
Department of Chemical & Process Engineering, University of Strathclyde, Glasgow, UK (McConnell J)
Online:2022-08-15
Published:2022-01-21
Contact:
Rafael A. García-Muñoz, PhD, rafael.garcia@urjc.es.
Supported by:
The financial support of the Spanish government (Grant No. CTQ2014-57858-R and CTQ2017-88642-R projects, to RAGM) was gratefully acknowledged.
Rafael A. García-Muñoz, Joseph McConnell, Victoria Morales, Raul Sanz. Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease[J]. Neural Regeneration Research, 2022, 17(8): 1743-1744.